C
Collegium Pharmaceutical, Inc.
Q3 2025 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2025(ET)
Revenue
This quarter$209M
Analyst estimate$189M▲ +10.7%
Year ago (Sep '24)$159M▲ +31.4%
EPS
This quarter$2.25
Analyst estimate$1.86▲ +21.0%
Year ago (Sep '24)$1.61▲ +39.8%
Revenue Growth Trajectory
+9%YoY
Last 6 quarters · 2 analysts